APA Insider Filing: 2,059 Shares Added, Beneficial Ownership Now 97,155
Rhea-AI Filing Summary
APA Corp (APA) director Chansoo Joung received equity awards and holds significant shares following routine director compensation actions. The Form 4 reports transactions dated 09/30/2025 showing 2,059 phantom stock units converted one-for-one into common shares, and 2,059 restricted stock units granted and recorded. After these transactions the filing shows Chansoo Joung beneficially owns 97,155 shares of APA common stock. The restricted stock units were granted under APA’s 2016 Omnibus Compensation Plan and certain units vested on 09/30/2025. The filing reflects these events as exempt acquisitions pursuant to Rule 16b-3 related to the company’s outside directors’ deferral program.
Positive
- Director received equity awards totaling 2,059 shares via phantom stock conversion and 2,059 restricted stock units on 09/30/2025
- Beneficial ownership increased to 97,155 shares following the reported transactions
- Awards granted under shareholder-approved plan (2016 Omnibus Compensation Plan) and treated as exempt under Rule 16b-3
Negative
- None.
Insights
TL;DR Director received routine equity compensation: conversions and grants totaling 2,059 shares, increasing reported beneficial ownership to 97,155 shares.
This Form 4 documents non-derivative and derivative-unit activity for a non-employee director on 09/30/2025. The reported phantom stock units were converted one-for-one into common shares and restricted stock units were both granted and shown as vested for portions of the award. The filing cites Rule 16b-3 exemptions and the 2016 Omnibus Compensation Plan as the grant vehicle, indicating these are standard director compensation mechanics rather than open-market trades or corporate control transactions.
TL;DR Compensation-related equity activity for an outside director; administrative and exempt under standard shareholder-approved plan.
The disclosure identifies the awards as governed by the shareholder-approved 2016 Omnibus Compensation Plan and the outside directors’ deferral program, with an attorney-in-fact signature on 10/01/2025. This aligns with routine governance practices for non-employee director compensation and appropriate Rule 16b-3 treatment for exempt acquisitions. No departures, sales, or unusual transfers are reported.